EUVIMEDEUVIMED entdecken
Crossref

YAP1 silencing enhances cisplatin efficacy in lung adenocarcinoma via activating mitochondrial apoptosis

Renfeng Xu, Saifan Zeng, Ting Zhang, Jingjing Wu, Juan Tang, Hongqin Yang, Feng Gao

Biomaterials Advances · 2026-09 · 186 · 214927

DOI: 10.1016/j.bioadv.2026.214927 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Advances, 2026-09. Verfasst von Renfeng Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Optoelectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory for Photonics Technol…. Hauptthemen laut MEDLINE: Cisplatin, Apoptosis, Transcription Factors, Mitochondria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fujian Provincial Health Commission, Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung adenocarcinoma (LUAD) remains one of the leading causes of cancer-related deaths worldwide, and cisplatin (DDP) resistance severely limits the efficacy of first-line chemotherapy. Extracellular matrix (ECM) stiffening is a hallmark of solid tumors, yet how it modulates chemosensitivity remains unclear. This study demonstrates that matrix stiffness activates the mechanosensor YAP1 in lung adenocarcinoma, which in turn establishes an apoptosis-refractory state by upregulating Bcl2 and downregulating Bax. Functional experiments establish the YAP1-Bax axis as the core pathway, while clinical correlation analysis reveals that YAP1 expression significantly predicts poor post-chemotherapy survival. Our findings reveal a mechanism by which mechanical cues desensitize mitochondrial apoptosis through YAP1-driven transcriptional reprogramming, providing both new insights into chemoresistance mechanisms and a potential biomarker for treatment response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinApoptosisTranscription FactorsMitochondriaAdenocarcinoma of LungLung NeoplasmsAdaptor Proteins, Signal TransducingGene SilencingAntineoplastic AgentsHumansYAP-Signaling ProteinsCell Line, Tumorbcl-2-Associated X ProteinDrug Resistance, Neoplasm

Stichwörter der Autor:innen

Cell apoptosisCisplatinLUADMatrix stiffnessYes-associated protein 1

Substanzen

CisplatinYAP-Signaling ProteinsTranscription FactorsAdaptor Proteins, Signal TransducingYAP1 protein, humanAntineoplastic Agentsbcl-2-Associated X Protein

Autor:innen und Institutionen

  • Key Laboratory of Optoelectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory for Photonics Technology, Fujian Normal University, Fuzhou, 350007, China.
  • Department of Pathology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China; Department of Pathology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fuji…
  • Department of Pathology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
  • Key Laboratory of Optoelectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory for Photonics Technology, Fujian Normal University, Fuzhou, 350007, China. Electronic addre…

Förderung

  • National Natural Science Foundation of China
  • Fujian Provincial Health Commission
  • Natural Science Foundation of Fujian Province

Zitieren

APA

Xu, R., Zeng, S., Zhang, T., Wu, J., Tang, J., Yang, H., & Gao, F. (2026). YAP1 silencing enhances cisplatin efficacy in lung adenocarcinoma via activating mitochondrial apoptosis. Biomaterials Advances, 186, 214927. https://doi.org/10.1016/j.bioadv.2026.214927

Vancouver

Xu R, Zeng S, Zhang T, Wu J, Tang J, Yang H, et al. YAP1 silencing enhances cisplatin efficacy in lung adenocarcinoma via activating mitochondrial apoptosis. Biomaterials Advances. 2026;186:214927. doi:10.1016/j.bioadv.2026.214927

BibTeX
@article{Xu2026,
  author = {Xu, Renfeng and Zeng, Saifan and Zhang, Ting and Wu, Jingjing and Tang, Juan and Yang, Hongqin and Gao, Feng},
  title = {YAP1 silencing enhances cisplatin efficacy in lung adenocarcinoma via activating mitochondrial apoptosis},
  journal = {Biomaterials Advances},
  year = {2026},
  volume = {186},
  pages = {214927},
  doi = {10.1016/j.bioadv.2026.214927}
}
Kostenlos starten →